These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13796218)

  • 1. Effect of ethyl-biscoumacetate (tromexan) on the serum lipid, protein and lipoprotein fractions in experimental atherosclerosis of chicks.
    BALKRISHNA ; CHAKRAVARTI RN; ZAIDI SH
    Indian J Med Sci; 1959 Jul; 13():578-83. PubMed ID: 13796218
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ethyl-biscoumacetate (tromexan) on the course and extent of experimental atherosclerosis in chicks.
    CHAKRAVARTI RN; ZAIDI SH
    Indian J Med Sci; 1959 Jul; 13():571-7. PubMed ID: 13809014
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of dicoumarol, tromexan, and heparin on thrombus propagation.
    CAREY LC; WILLIAMS RD
    Ann Surg; 1960 Nov; 152(5):919-22. PubMed ID: 13690778
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of iodine therapy of lipoid, protein and lipoprotein blood fractions and basal metabolism in patients with atherosclerosis].
    PITEL' NIa
    Ter Arkh; 1962 Apr; 34():53-7. PubMed ID: 14486969
    [No Abstract]   [Full Text] [Related]  

  • 5. Dicumarol, coumadin, marcumar and tromexan; comparative study of their action on the clot as registered by the thrombelastogram.
    ESCUDERO J; McDEVITT E; WRIGHT IS
    Circulation; 1959 Sep; 20():405-12. PubMed ID: 13820773
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modifications of heparin activity in the blood after tromexan administration].
    COSTANTINI A; TINTORI M
    Boll Soc Ital Biol Sper; 1951 Dec; 27(12):1655-7. PubMed ID: 14934909
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of chlorpomazine on lipid, lipoprotein and protein level and on lipoprotein lipase activity in human blood serum].
    KAI J
    Pol Arch Med Wewn; 1961; 31():807-18. PubMed ID: 13750762
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethyl biscoumacetate (tromexan) in human milk.
    ILLINGWORTH RS; FINCH E
    J Obstet Gynaecol Br Emp; 1959 Jun; 66():487-8. PubMed ID: 13852719
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of ethyl biscoumacetate (tromexan).
    VANDER VEER JB; FUNK EH; BOYER FR; KELLER EA
    Am J Med; 1953 Jun; 14(6):694-703. PubMed ID: 13057879
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative studies on the effect of dicumarol and tromexan on prothrombin level, capillary resistance and capillary permeability].
    LINKE A
    Dtsch Med Wochenschr; 1952 Jun; 77(24):775-80. PubMed ID: 14936621
    [No Abstract]   [Full Text] [Related]  

  • 11. The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.
    BURNS JJ; WEINER M; SIMSON G; BRODIE BB
    J Pharmacol Exp Ther; 1953 May; 108(1):33-41. PubMed ID: 13053419
    [No Abstract]   [Full Text] [Related]  

  • 12. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.
    BRODIE BB; WEINER M; BURNS JJ; SIMSON G; YALE EK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):453-63. PubMed ID: 13023556
    [No Abstract]   [Full Text] [Related]  

  • 13. Spectrophotometric determination of Tromexan in plasma and serum.
    RIEDERS F; GRUBER CM
    Proc Soc Exp Biol Med; 1951 Aug; 77(4):684-6. PubMed ID: 14891838
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of small and medium doses of estrogens on the lipid, lipoprotein and protein fractions in the blood serum of patients with climacteric neuroses].
    RAFAL'SKII IaD
    Probl Endokrinol Gormonoter; 1962; 8():52-8. PubMed ID: 14489816
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethyl biscoumacetate (tromexan) in coronary artery disease.
    POLLITZER RS
    J S C Med Assoc (Columbia); 1953 Mar; 49(3):66-8. PubMed ID: 13045283
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of action of tromexan].
    COSTANTINI A; TINTORI M
    Boll Soc Ital Biol Sper; 1951 Dec; 27(12):1652-5. PubMed ID: 14934908
    [No Abstract]   [Full Text] [Related]  

  • 17. LIPOPROTEIN IMMUNIZATION AND INDUCED ATHEROSCLEROSIS IN RABBITS. 1. COCKEREL BETA-LIPOPROTEINS AS ANTIGENS.
    BAILEY JM; TOMAR R
    J Atheroscler Res; 1965; 5(2):203-14. PubMed ID: 14273070
    [No Abstract]   [Full Text] [Related]  

  • 18. ON THE CONCEPT OF SLOWLY AND RAPIDLY ACTING COUMARIN DRUGS.
    VERSTRAETE M; HELLEMANS J; VERMYLEN C; VORLAT M
    Acta Haematol; 1963; 30():181-9. PubMed ID: 14056130
    [No Abstract]   [Full Text] [Related]  

  • 19. Mode of action of tromexan.
    HUNTER RB; TUDHOPE GR
    Lancet; 1953 Apr; 1(6765):821-3. PubMed ID: 13036185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prophylaxis of thrombosis with tromexan in closed fractures of the leg].
    GLOOR F; SIGG B
    Praxis; 1950 Sep; 39(39):839-40. PubMed ID: 14786168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.